ORTX - Orchard Therapeutics PLC (ORTX) CEO Bobby Gaspar on Q1 2022 Results - Earnings Call Transcript
Orchard Therapeutics PLC (ORTX) Q1 2022 Earnings Conference Call May 12, 2022, 08:00 ET Company Participants Bobby Gaspar - CEO Braden Parker - Chief Commercial Officer Frank Thomas - President & COO Leslie Meltzer - Chief Medical Officer Conference Call Participants Brendan Smith - Cowen and Company Dae Gon Ha - Stifel, Nicolaus & Company Pete Stavropoulos - Cantor Fitzgerald & Co. David Hoang - SMBC Tessa Romero - JPMorgan Chase & Co/ Presentation Operator Welcome to the Orchard Therapeutics Q1 2022 Earnings Conference Call. My name is John. I'll be operator for today's call. During the question-and-answer session, if you do have a question, pre-1 on your touchtone phone. I will now turn the call over to Bobby Gaspar. Bobby Gaspar Hello, everyone, and welcome to Orchard Therapeutics First Quarter 2022 Financial Results and Corporate Update Webcast. I'm CEO and Co-Founder, Bobby Gaspar. Before we get started, I want
For further details see:
Orchard Therapeutics PLC (ORTX) CEO Bobby Gaspar on Q1 2022 Results - Earnings Call Transcript